Aurinia Pharmaceuticals Inc (AUPH)

May 16, 2025

Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 16, 2025

May 15, 2025

Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks

May 15, 2025

May 15, 2025

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

May 15, 2025

May 15, 2025

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025

May 15, 2025

Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com

May 15, 2025

May 14, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN

May 14, 2025

May 14, 2025

Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa

May 14, 2025

May 14, 2025

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

May 14, 2025

May 13, 2025

Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN

May 13, 2025

May 13, 2025

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

May 13, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025

May 12, 2025

Document - SEC.gov

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks

May 12, 2025

May 12, 2025

Aurinia: Q1 Earnings Snapshot - MySA

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025

May 12, 2025

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

May 12, 2025

May 12, 2025

Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

May 12, 2025

May 12, 2025

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India

May 12, 2025

May 12, 2025

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance - marketscreener.com

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Inc. Reiterates Guidance for the Full Year 2025 - marketscreener.com

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire

May 12, 2025

May 09, 2025

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

May 09, 2025

May 06, 2025

How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

May 06, 2025

May 05, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - BioSpace

May 05, 2025

Apr 30, 2025

Glass Lewis Supports Aurinia’s Proposals for 2025 AGM - TipRanks

Apr 30, 2025

Apr 30, 2025

ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting - TipRanks

Apr 30, 2025

Apr 30, 2025

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - The Globe and Mail

Apr 30, 2025

Apr 29, 2025

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - BioSpace

Apr 29, 2025

Apr 29, 2025

Aurinia Pharmaceuticals (AUPH) Gains Support from ISS for Board - GuruFocus

Apr 29, 2025

Apr 28, 2025

Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025

Apr 26, 2025

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Apr 26, 2025

Apr 25, 2025

Aurinia Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Zacks Investment Research

Apr 24, 2025

Apr 23, 2025

Concerned Shareholders Of Aurinia Pharmaceuticals Announce Their Intention To Withhold Support For CEO Peter Greenleaf At 2025 Annual Meeting - TradingView

Apr 23, 2025

Apr 23, 2025

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting - Business Wire

Apr 23, 2025

Apr 23, 2025

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Yahoo Finance

Apr 23, 2025

Apr 19, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Apr 19, 2025

Apr 17, 2025

Aurinia Sues Galenicum to Block Copies of Lupkynis Kidney Drug - Bloomberg Law News

Apr 17, 2025

Apr 11, 2025

Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement - Law360

Apr 11, 2025

Apr 07, 2025

High Growth Tech Stocks To Watch In The US Market - simplywall.st

Apr 07, 2025